 |
PDBsum entry 1rtk
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hormone/growth factor
|
PDB id
|
|
|
|
1rtk
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.21.47
- alternative-complement-pathway C3/C5 convertase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Cleaves C3 in the alpha-chain to yield C3a and C3b. Cleaves C5 in the alpha-chain to yield C5a and C5b. Both cleavages take place at the C-terminal of an arginine residue.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Mol Cell
14:17-28
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural analysis of engineered Bb fragment of complement factor B: insights into the activation mechanism of the alternative pathway C3-convertase.
|
|
K.Ponnuraj,
Y.Xu,
K.Macon,
D.Moore,
J.E.Volanakis,
S.V.Narayana.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The C-terminal fragment, Bb, of factor B combines with C3b to form the pivotal
C3-convertase, C3bBb, of alternative complement pathway. Bb consists of a von
Willebrand factor type A (vWFA) domain that is structurally similar to the I
domains of integrins and a serine protease (SP) domain that is in inactive
conformation. The structure of the C3bBb complex would be important in
deciphering the activation mechanism of the SP domain. However, C3bBb is labile
and not amenable to X-ray diffraction studies. We engineered a disulfide bond in
the vWFA domain of Bb homologous to that shown to lock I domains in active
conformation. The crystal structures of Bb(C428-C435) and its inhibitor
complexes reveal that the adoption of the "active" conformation by the
vWFA domain is not sufficient to activate the C3-convertase catalytic apparatus
and also provide insights into the possible mode of C3-convertase activation.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Cartoon Representation of C3-Convertase
FormationC3b attached to an activating surface binds factor B,
which undergoes conformational changes suitable for the cleavage
by factor D, resulting in C3-convertase formation.
|
 |
Figure 5.
Figure 5. Structures of Bb^C428-C435 Inhibitor Complexes(A)
Superposition of the active sites of Bb^C428-C435 (gold) and
Bb^C428-C435-BCX583 (light green) crystal structures. The
inhibitor (BCX583) covalently linked to Ser^195 is held in
position by hydrogen bonding to Asp^715(226) through a water
molecule (lavender). The L2 loop (red) is seen only in the
inhibitor complex structure.(B) Comparison of the active sites
of Bb^C428-C435-DIP and Bb^C428-C435. The backbone of the
inhibitor-bound Bb^C428-C435 is shown in light green color,
while the inhibitor-free Bb^C428-C435 is shown in gold color.
Covalently bound DIP molecule points its phosphoryl oxygen into
the putative oxyanion hole (marked with black star) and forces
it to acquire a tight β turn from a zymogen-like 3[10] helix
(transparent red color) conformation.(C) Stereo close-up of the
superposition of the 670(191)-674(194) segment of Bb^C428-C435
(gold) and Bb^C428-C435-DIP complex (light green). The
orientational difference of carbonyl oxygen of the residue
671(192) is indicated in the boxed area.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Mol Cell
(2004,
14,
17-28)
copyright 2004.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
K.Vengadesan,
and
S.V.Narayana
(2011).
Structural biology of gram-positive bacterial adhesins.
|
| |
Protein Sci,
20,
759-772.
|
 |
|
|
|
|
 |
A.D.Vogt,
A.Bah,
and
E.Di Cera
(2010).
Evidence of the E*-E equilibrium from rapid kinetics of Na+ binding to activated protein C and factor Xa.
|
| |
J Phys Chem B,
114,
16125-16130.
|
 |
|
|
|
|
 |
D.Serruto,
R.Rappuoli,
M.Scarselli,
P.Gros,
and
J.A.van Strijp
(2010).
Molecular mechanisms of complement evasion: learning from staphylococci and meningococci.
|
| |
Nat Rev Microbiol,
8,
393-399.
|
 |
|
|
|
|
 |
H.Tawadrous,
T.Maga,
J.Sharma,
J.Kupferman,
R.J.Smith,
and
M.Schoeneman
(2010).
A novel mutation in the complement factor B gene (CFB) and atypical hemolytic uremic syndrome.
|
| |
Pediatr Nephrol,
25,
947-951.
|
 |
|
|
|
|
 |
S.Fu,
X.Tong,
C.Cai,
Y.Zhao,
Y.Wu,
Y.Li,
J.Xu,
X.C.Zhang,
L.Xu,
W.Chen,
and
Z.Rao
(2010).
The structure of tumor endothelial marker 8 (TEM8) extracellular domain and implications for its receptor function for recognizing anthrax toxin.
|
| |
PLoS One,
5,
e11203.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Z.Chen,
L.A.Pelc,
and
E.Di Cera
(2010).
Crystal structure of prethrombin-1.
|
| |
Proc Natl Acad Sci U S A,
107,
19278-19283.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Bah,
C.J.Carrell,
Z.Chen,
P.S.Gandhi,
and
E.Di Cera
(2009).
Stabilization of the E* form turns thrombin into an anticoagulant.
|
| |
J Biol Chem,
284,
20034-20040.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.J.Janssen,
L.Gomes,
R.I.Koning,
D.I.Svergun,
A.J.Koster,
D.C.Fritzinger,
C.W.Vogel,
and
P.Gros
(2009).
Insights into complement convertase formation based on the structure of the factor B-cobra venom factor complex.
|
| |
EMBO J,
28,
2469-2478.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.Di Cera
(2009).
Serine proteases.
|
| |
IUBMB Life,
61,
510-515.
|
 |
|
|
|
|
 |
E.Torreira,
A.Tortajada,
T.Montes,
S.R.de Córdoba,
and
O.Llorca
(2009).
3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertase.
|
| |
Proc Natl Acad Sci U S A,
106,
882-887.
|
 |
|
|
|
|
 |
P.S.Gandhi,
M.J.Page,
Z.Chen,
L.Bush-Pelc,
and
E.Di Cera
(2009).
Mechanism of the anticoagulant activity of thrombin mutant W215A/E217A.
|
| |
J Biol Chem,
284,
24098-24105.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.H.Rooijakkers,
J.Wu,
M.Ruyken,
R.van Domselaar,
K.L.Planken,
A.Tzekou,
D.Ricklin,
J.D.Lambris,
B.J.Janssen,
J.A.van Strijp,
and
P.Gros
(2009).
Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.
|
| |
Nat Immunol,
10,
721-727.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
V.Krishnan,
Y.Xu,
K.Macon,
J.E.Volanakis,
and
S.V.Narayana
(2009).
The structure of C2b, a fragment of complement component C2 produced during C3 convertase formation.
|
| |
Acta Crystallogr D Biol Crystallogr,
65,
266-274.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
W.Niu,
Z.Chen,
L.A.Bush-Pelc,
A.Bah,
P.S.Gandhi,
and
E.Di Cera
(2009).
Mutant N143P reveals how Na+ activates thrombin.
|
| |
J Biol Chem,
284,
36175-36185.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.Gros,
F.J.Milder,
and
B.J.Janssen
(2008).
Complement driven by conformational changes.
|
| |
Nat Rev Immunol,
8,
48-58.
|
 |
|
|
|
|
 |
B.J.Janssen,
E.F.Halff,
J.D.Lambris,
and
P.Gros
(2007).
Structure of compstatin in complex with complement component C3c reveals a new mechanism of complement inhibition.
|
| |
J Biol Chem,
282,
29241-29247.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.Goicoechea de Jorge,
C.L.Harris,
J.Esparza-Gordillo,
L.Carreras,
E.A.Arranz,
C.A.Garrido,
M.López-Trascasa,
P.Sánchez-Corral,
B.P.Morgan,
and
S.Rodríguez de Córdoba
(2007).
Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome.
|
| |
Proc Natl Acad Sci U S A,
104,
240-245.
|
 |
|
|
|
|
 |
F.J.Milder,
L.Gomes,
A.Schouten,
B.J.Janssen,
E.G.Huizinga,
R.A.Romijn,
W.Hemrika,
A.Roos,
M.R.Daha,
and
P.Gros
(2007).
Factor B structure provides insights into activation of the central protease of the complement system.
|
| |
Nat Struct Mol Biol,
14,
224-228.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.T.Le,
G.Abbenante,
and
D.P.Fairlie
(2007).
Profiling the enzymatic properties and inhibition of human complement factor B.
|
| |
J Biol Chem,
282,
34809-34816.
|
 |
|
|
|
|
 |
V.Krishnan,
Y.Xu,
K.Macon,
J.E.Volanakis,
and
S.V.Narayana
(2007).
The crystal structure of C2a, the catalytic fragment of classical pathway C3 and C5 convertase of human complement.
|
| |
J Mol Biol,
367,
224-233.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
F.J.Milder,
H.C.Raaijmakers,
M.D.Vandeputte,
A.Schouten,
E.G.Huizinga,
R.A.Romijn,
W.Hemrika,
A.Roos,
M.R.Daha,
and
P.Gros
(2006).
Structure of complement component C2A: implications for convertase formation and substrate binding.
|
| |
Structure,
14,
1587-1597.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.A.Springer
(2006).
Complement and the multifaceted functions of VWA and integrin I domains.
|
| |
Structure,
14,
1611-1616.
|
 |
|
|
|
|
 |
S.H.Rooijakkers,
M.Ruyken,
A.Roos,
M.R.Daha,
J.S.Presanis,
R.B.Sim,
W.J.van Wamel,
K.P.van Kessel,
and
J.A.van Strijp
(2005).
Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases.
|
| |
Nat Immunol,
6,
920-927.
|
 |
|
|
|
|
 |
G.Hauptmann,
and
S.Bahram
(2004).
Genetics of the central MHC.
|
| |
Curr Opin Immunol,
16,
668-672.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |